Does an early invasive strategy reduce major cardiac events in patients with unstable angina and NSTEMI treated with tirofiban?
Patients with unstable angina and myocardial infarction without ST-segment elevation treated with the glycoprotein IIb/IIIa inhibitor tirofiban
Early invasive strategy
Conservative strategy
Incidence of major cardiac eventscomposite
An early invasive strategy significantly reduces major cardiac events in patients with unstable angina and NSTEMI receiving glycoprotein IIb/IIIa inhibition.
In patients with unstable angina and myocardial infarction without ST-segment elevation who were treated with the glycoprotein IIb/IIIa inhibitor tirofiban, the use of an early invasive strategy significantly reduced the incidence of major cardiac events. These data support a policy involving broader use of the early inhibition of glycoprotein IIb/IIIa in combination with an early invasive strategy in such patients.
Building similarity graph...
Analyzing shared references across papers
Loading...
Christopher P. Cannon
Université Claude Bernard Lyon 1
William S. Weintraub
Interventional Cardiology
Laura A. Demopoulos
Inserm
New England Journal of Medicine
Brigham and Women's Hospital
Emory University
Baylor College of Medicine
Building similarity graph...
Analyzing shared references across papers
Loading...
Cannon et al. (Thu,) studied this question.
synapsesocial.com/papers/69cdb9260f58ee388d46c47b — DOI: https://doi.org/10.1056/nejm200106213442501